Drug susceptibility of slowly growing nontuberculous mycobacteria (sNTM) isolated in the European part of Russian Federation T. Smirnova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), S. Andreevskaya (Moscow, Russian Federation), I. Andrievskaya (Moscow, Russian Federation), E. Kiseleva (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation)
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Disease area: Respiratory infectionsRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Smirnova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), S. Andreevskaya (Moscow, Russian Federation), I. Andrievskaya (Moscow, Russian Federation), E. Kiseleva (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation). Drug susceptibility of slowly growing nontuberculous mycobacteria (sNTM) isolated in the European part of Russian Federation. 536
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Drug resistance of Mycobacterium tuberculosis in the Ural region of Russian Federation Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Estimation of XDR-TB in European part of the Russian Federation Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Identification of cultures consisting of two species of mycobacteria from patients in the Russian Federation Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020
Drug-resistant tuberculosis in the European Union and European economic area Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible? Year: 2015
European Respiratory Society International Congress, Madrid, 2019: nontuberculous mycobacterial pulmonary disease highlights Source: ERJ Open Res, 6 (4) 00317-2020; 10.1183/23120541.00317-2020 Year: 2020
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012
Extensively drug-resistant tuberculosis in the penitentiary facilities of the Russian Federation Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014
Drug resistance of Nontuberculous mycobacteria in Siberia Source: International Congress 2019 – Paediatric tuberculosis Year: 2019
XDR-TB prevalence in some regions of the Russian Federation Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017
The distribution of Beijing genotype among mycobacterium tuberculosis strains obtained from patients of different dispensary registration groups from Nizhny Novgorod region of the Russian Federation in 2013-2014 Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002
European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations Source: Eur Respir J, 52 (5) 1801617; 10.1183/13993003.01617-2018 Year: 2018
European Union Standards for Tuberculosis Care Source: Eur Respir J 2012; 39: 807-819 Year: 2012
New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC) Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Population-based study of fluoroquinolone-resistance in clinical isolates of Mycobacterium tuberculosis in Novosibirsk Oblast, Russian Federation Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union Source: Eur Respir J , 49 (3) 1601992; DOI: 10.1183/13993003.01992-2016 Year: 2017
The European Respiratory Journal targets tuberculosis Source: Eur Respir J 2010; 36: 714-715 Year: 2010
Drug resistant tuberculosis in Belarus Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003
Clinical profile of drug resistant tuberculosis in Pediatric Population, India. Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017